Program Committee
-
E. Stewart Geary, MD MD, Global Safety Officer
Eisai Co., Ltd., Japan -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan -
Katsuhiko Ichimaru Review Director, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Kazuhiko Ishida, MSc, RPh Director, Pharmacovigilance
Astellas Pharma Inc., Japan -
Tomoyuki Kakizume, PhD
Daiichi Sankyo Co., Ltd., Japan -
Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
Pfizer R&D Japan G.K., Japan -
Yukihiro Matsuda, MSc Director, Clinical Delivery
ICON Clinical Research GK, Japan -
Yukiko Nishimura, PhD, MSc Director
Advocacy Service for Rare and Intractable Diseases, Japan
Have an account?